Digital Quantification of DNA Replication and Chromosome Segregation Enables Determination of Antimicrobial Susceptibility after only 15 Minutes of Antibiotic Exposure
Abstract
Rapid antimicrobial susceptibility testing (AST) would decrease misuse and overuse of antibiotics. The "holy grail" of AST is a phenotype-based test that can be performed within a doctor visit. Such a test requires the ability to determine a pathogen's susceptibility after only a short antibiotic exposure. Herein, digital PCR (dPCR) was employed to test whether measuring DNA replication of the target pathogen through digital single-molecule counting would shorten the required time of antibiotic exposure. Partitioning bacterial chromosomal DNA into many small volumes during dPCR enabled AST results after short exposure times by 1) precise quantification and 2) a measurement of how antibiotics affect the states of macromolecular assembly of bacterial chromosomes. This digital AST (dAST) determined susceptibility of clinical isolates from urinary tract infections (UTIs) after 15 min of exposure for all four antibiotic classes relevant to UTIs. This work lays the foundation to develop a rapid, point-of-care AST and strengthen global antibiotic stewardship.
Additional Information
© 2016 WILEY-VCH Verlag GmbH & Co. Received: March 29, 2016. Revised: May 5, 2016. Version of Record online: 30 Jun 2016. This research was supported by DARPA Cooperative Agreement HR0011-11-2-0006, NIH Grant R01EB012946, and a grant from the Joseph J. Jacobs Institute for Molecular Engineering for Medicine. We thank Shelley Miller for advice and experimental assistance. We thank Natasha Shelby for contributions to writing and editing this manuscript.Errata
In the "Antibiotic exposure time course experiments" section of the "Experimental Section" of the Supporting Information for this Communication, "early logarithmic" should read "early stationary (OD600 3.1–6.9)." Also, the authors do not recommend the use of Epicentre QuickExtract RNA Extraction Solution for pathogens because they found that this solution does not reproducibly and completely lyse some clinical E. coli isolates, which could present a biohazard unless the extracts are handled at the appropriate biosafety level.Attached Files
Accepted Version - nihms832692.pdf
Supplemental Material - ange201602763-sup-0001-misc_information.pdf
Files
Name | Size | Download all |
---|---|---|
md5:f95eb7c8a4ba2432e3ce1fea12df4b71
|
1.4 MB | Preview Download |
md5:ad48af7c9ada8cf119b501cdcb9b5e7d
|
680.2 kB | Preview Download |
Additional details
- PMCID
- PMC5215780
- Eprint ID
- 68822
- Resolver ID
- CaltechAUTHORS:20160705-083001025
- Defense Advanced Research Projects Agency (DARPA)
- HR0011-11-2-0006
- NIH
- R01EB012946
- Joseph J. Jacobs Institute for Molecular Engineering for Medicine
- Created
-
2016-07-05Created from EPrint's datestamp field
- Updated
-
2023-04-19Created from EPrint's last_modified field
- Caltech groups
- Jacobs Institute for Molecular Engineering for Medicine